Tag: special interest AEs

Case Studies: Special Interest AEs & AESIs That Strengthened Safety Oversight In the realm of clinical trials, particularly in medidata clinical trials, safety oversight is paramount. The evolution of adverse event (AE) reporting and management has become increasingly intricate, with a particular focus on special interest AEs (SIAEs) and adverse events of special interest (AESIs)….

Read More “Case Studies: Special Interest AEs & AESIs That Strengthened Safety Oversight” »

Common Pitfalls in Special Interest AEs & AESIs—and How to Avoid Regulatory Findings Understanding Special Interest Adverse Events (AEs) and Adverse Events of Special Interest (AESIs) Adverse events (AEs) are any undesirable experiences associated with the use of a medical product in a patient. The categorization as either a general AE or a special interest…

Read More “Common Pitfalls in Special Interest AEs & AESIs—and How to Avoid Regulatory Findings” »

Aligning Special Interest AEs & AESIs With GCP, ICH E2A–E2F and Local Regulations In the realm of clinical trials, the accurate reporting and management of adverse events (AEs) and adverse events of special interest (AESIs) is paramount. This necessity stems not only from regulatory demands but also from the intrinsic need for patient safety and…

Read More “Aligning Special Interest AEs & AESIs With GCP, ICH E2A–E2F and Local Regulations” »

Digital Tools and Automation to Streamline Special Interest AEs & AESIs Digital Tools and Automation to Streamline Special Interest AEs & AESIs In the realm of clinical research, particularly concerning eCRF clinical trials, the accurate management and reporting of adverse events (AEs) and special interest adverse events (AESIs) is paramount. Special interest AEs and AESIs…

Read More “Digital Tools and Automation to Streamline Special Interest AEs & AESIs” »

Special Interest AEs & AESIs: End-to-End Compliance Framework for Global Clinical Trials Special Interest AEs & AESIs: End-to-End Compliance Framework for Global Clinical Trials Clinical trials are crucial for advancing medical science and delivering new therapies to patients. Among the many aspects of clinical trial management, the identification, reporting, and management of adverse events (AEs)…

Read More “Special Interest AEs & AESIs: End-to-End Compliance Framework for Global Clinical Trials” »

How to Design Special Interest AEs & AESIs That Meets FDA, EMA and MHRA Expectations How to Design Special Interest AEs & AESIs That Meets FDA, EMA and MHRA Expectations This comprehensive guide offers clinical operations, regulatory affairs, and medical affairs professionals a clear, systematic approach to designing Special Interest Adverse Events (AEs) and Adverse…

Read More “How to Design Special Interest AEs & AESIs That Meets FDA, EMA and MHRA Expectations” »

Special Interest AEs & AESIs in Practice: Step-by-Step Guide for Sponsors and CROs Special Interest AEs & AESIs in Practice: Step-by-Step Guide for Sponsors and CROs In the complex landscape of clinical trials, sponsors and Contract Research Organizations (CROs) face a myriad of challenges while ensuring compliance with regulatory standards. One critical area of focus…

Read More “Special Interest AEs & AESIs in Practice: Step-by-Step Guide for Sponsors and CROs” »